London Daily

Focus on the big picture.
Sunday, Dec 14, 2025

Competition regulator to investigate antibiotics price rise following surge in Strep A cases

Competition regulator to investigate antibiotics price rise following surge in Strep A cases

The CMA is "ready to take action" after stressing that it is illegal for companies to "charge excessive prices," amid reports one box of antibiotics was being sold for up to £19.
An investigation has been launched by the Competition and Markets Authority (CMA) following rocketing prices of antibiotics in the wake of Strep A cases.

Drug companies have been accused of hiking prices after some pharmacies said they were being charged up to £19 for a box of drugs that normally costs a few pounds.

Pharmacies say they are losing thousands per week as they can only recoup a fraction of the cost of drugs from the NHS.

They are also reporting that parents are having to go from pharmacy to pharmacy trying to find drugs for poorly children, as they struggle to get hold of antibiotics.

On Monday, the Department of Health issued a medicine supply notification for antibiotics for the treatment of Strep A. It said that supplies "may be temporarily limited in supply" at certain wholesalers and pharmacies.

This followed a statement by Health Secretary Steve Barclay, who said there was no shortage of antibiotics and stock could be moved around if any particular area was experiencing problems with supply.

Now, a spokesperson for the CMA has said: "People have got real concerns about the price of antibiotics used to treat Strep A, and we want companies to be clear about their obligations under the law.

"There should be no doubt that it is illegal for a dominant company to charge excessive prices, or for any companies to collude to drive up prices.

"We are working to establish the facts of what is currently happening in the market and welcome new information as part of our work.

"We stand ready to take action if there is evidence of anti-competitive behaviour that breaks the law."

Last week, one pharmaceutical leader told Sky News that shortages have been driven by "complicated supply chains" for medications and the raw materials used to make them, in many different parts of the world.

However, the industry has also seen "volatile spikes in demand for drugs" - following a sharp decline in demand during the COVID-19 pandemic, when people were not mixing or seeing GPs.

The Department of Health and Social Care told Sky News at the time, that it is "normal" for prices to "fluctuate based on demand".

The Association of Independent Multiple Pharmacies (AIMP) has urged the government to take action, as the problem is getting worse.

Faheem Ahmed told Sky News he had just three boxes of antibiotics - with many out of stock. He said in the 10 years since he qualified, he has never known a shortage of the drug.

"I hope it is temporary, but we are dealing with bacteria here, so when you say temporary, these bacteria multiply in minutes, seconds," he said.

"They are not going to wait for two, three, four days so whether it is temporary or long-term, if you look at it from a scientific level…the infection is going to spread."

A Department of Health and Social Care spokesman said on Wednesday: "Manufacturers currently have supplies of antibiotics available to treat Strep A.

"We continue to work urgently with manufacturers and wholesalers to expedite deliveries, bring forward stock they have to help ensure it gets to where it's needed and boost supply to meet demand as quickly as possible and support access to these vital medicines."
Newsletter

Related Articles

0:00
0:00
Close
UK Government Declines to Comment After ICC Prosecutor Alleges Britain Threatened to Defund Court Over Israel Arrest Warrant
Apple Shutters All Retail Stores in the United Kingdom Under New National COVID-19 Lockdown
US–UK Technology Partnership Strains as Key Trade Disagreements Emerge
UK Police Confirm No Further Action Over Allegation That Andrew Asked Bodyguard to Investigate Virginia Giuffre
Giuffre Family Expresses Deep Disappointment as UK Police Decline New Inquiry Into Andrew Mountbatten-Windsor Claims
Transatlantic Trade Ambitions Hit a Snag as UK–US Deal Faces Emerging Challenges
Ex-ICC Prosecutor Alleges UK Threatened to Withdraw Funding Over Netanyahu Arrest Warrant Bid
UK Disciplinary Tribunal Clears Carter-Ruck Lawyer of Misconduct in OneCoin Case
‘Pink Ladies’ Emerge as Prominent Face of UK Anti-Immigration Protests
Nigel Farage Says Reform UK Has Become Britain’s Largest Party as Labour Membership Falls Sharply
Google DeepMind and UK Government Launch First Automated AI Lab to Accelerate Scientific Discovery
UK Economy Falters Ahead of Budget as Growth Contracts and Confidence Wanes
Australia Approves Increased Foreign Stake in Strategic Defence Shipbuilder
Former UK Prime Minister Boris Johnson proclaims, “For Ukraine, surrendering their land would be a nightmare.”
Microsoft Challenges £2.1 Billion UK Cloud Licensing Lawsuit at Competition Tribunal
Fake Doctor in Uttar Pradesh Accused of Killing Woman After Performing YouTube-Based Surgery
Hackers Are Hiding Malware in Open-Source Tools and IDE Extensions
Traveling to USA? Homeland Security moving toward requiring foreign travelers to share social media history
UK Officials Push Back at Trump Saying European Leaders ‘Talk Too Much’ About Ukraine
UK Warns of Escalating Cyber Assault Linked to Putin’s State-Backed Operations
UK Consumer Spending Falters in November as Households Hold Back Ahead of Budget
UK Orders Fresh Review of Prince Harry’s Security Status After Formal Request
U.S. Authorises Nvidia to Sell H200 AI Chips to China Under Security Controls
Trump in Direct Assault: European Leaders Are Weak, Immigration a Disaster. Russia Is Strong and Big — and Will Win
"App recommendation" or disguised advertisement? ChatGPT Premium users are furious
"The Great Filtering": Australia Blocks Hundreds of Thousands of Minors From Social Networks
Mark Zuckerberg Pulls Back From Metaverse After $70 Billion Loss as Meta Shifts Priorities to AI
Nvidia CEO Says U.S. Data-Center Builds Take Years while China ‘Builds a Hospital in a Weekend’
Indian Airports in Turmoil as IndiGo Cancels Over a Thousand Flights, Stranding Thousands
Hollywood Industry on Edge as Netflix Secures Near-$60 Bln Loan for Warner Bros Takeover
Drugs and Assassinations: The Connection Between the Italian Mafia and Football Ultras
Hollywood megadeal: Netflix acquires Warner Bros. Discovery for 83 billion dollars
The Disregard for a Europe ‘in Danger of Erasure,’ the Shift Toward Russia: Trump’s Strategic Policy Document
Two and a Half Weeks After the Major Outage: A Cloudflare Malfunction Brings Down Multiple Sites
UK data-regulator demands urgent clarity on racial bias in police facial-recognition systems
Labour Uses Biscuits to Explain UK Debt — MPs Lean Into Social Media to Reach New Audiences
German President Lays Wreath at Coventry as UK-Germany Reaffirm Unity Against Russia’s Threat
UK Inquiry Finds Putin ‘Morally Responsible’ for 2018 Novichok Death — London Imposes Broad Sanctions on GRU
India backs down on plan to mandate government “Sanchar Saathi” app on all smartphones
King Charles Welcomes German President Steinmeier to UK in First State Visit by Berlin in 27 Years
UK Plans Major Cutback to Jury Trials as Crown Court Backlog Nears 80,000
UK Government to Significantly Limit Jury Trials in England and Wales
U.S. and U.K. Seal Drug-Pricing Deal: Britain Agrees to Pay More, U.S. Lifts Tariffs
UK Postpones Decision Yet Again on China’s Proposed Mega-Embassy in London
Head of UK Budget Watchdog Resigns After Premature Leak of Reeves’ Budget Report
Car-sharing giant Zipcar to exit UK market by end of 2025
Reports of Widespread Drone Deployment Raise Privacy and Security Questions in the UK
UK Signals Security Concerns Over China While Pursuing Stronger Trade Links
Google warns of AI “irrationality” just as Gemini 3 launch rattles markets
Top Consultancies Freeze Starting Salaries as AI Threatens ‘Pyramid’ Model
×